

Fundamental dimension Equity attribute | NUPeer $15.16▲+2.92% Cap $73.23BP/E 20.5x QuantScore53/100 | AFRMLeader $70.57▼-2.53% Cap $20.95BP/E 12.4x QuantScore65/100 | MELIPeer $1,839.72▲+0.31% Cap $93.27BP/E 50.1x QuantScore58/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical | |||
64/100 |
45/100 |
84/100 |
Valuation Multiples, PEG & DCF upside | 75/100 | 67/100 | 38/100 |
Health Piotroski, Altman Z, leverage & liquidity | 7/100 | 32/100 | 34/100 |
Growth Revenue / earnings growth & margins | 88/100 | 91/100 | 73/100 |
Sentiment Analyst ratings, targets & revisions | 29/100 | 88/100 | 59/100 |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | 20.5x | 12.4x | 50.1x |
Forward P/E (next FY) | 17.4x | 35.5x | 48.0x |
EV / EBITDA (TTM) | 21.1x | 22.7x | 30.3x |
Price / Sales | 3.8x | 5.0x | 2.7x |
Price / Free Cash Flow | -17.4x | 21.1x | 7.9x |
PEG ratio | 0.38 | 0.00 | -5.41 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 4 / 9 | 5 / 9 | 5 / 9 |
Altman Z-Score | 0.73 (Distress) | 1.84 (Grey) | 2.41 (Grey) |
Total debt / equity | 3.17 | 1.79 | 1.68 |
Quick ratio | 0.2x | 12.7x | 1.1x |
Interest coverage | 0.8x | 1.4x | 14.5x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | +43.0% | +22.5% | +39.1% |
Net income growth YoY | +45.5% | +3597.9% | +4.5% |
Gross margin (TTM) | 44.0% | 68.1% | 42.7% |
Operating margin (FY) | 24.4% | 22.1% | 11.1% |
FCF margin (FY) | 22.0% | 25.1% | 37.3% |
5. Trailing price performancePrice change over period |
1M return | +11.8% | -2.1% | +2.9% |
3M return | +7.6% | -0.2% | +1.4% |
6M return | +4.5% | +10.0% | -0.9% |
Year to date | -9.4% | -5.8% | -8.7% |
1Y return | -4.3% | -7.0% | -12.5% |
3Y return | +87.6% | +258.3% | +55.9% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $15.40 +1.6% upside | $-94.94 -234.5% premium | $422.46 -77.0% premium |
Wall Street consensus target | $16.92 +11.6% · range $13.00–$20.50 | $95.79 +35.7% · range $75.00–$115.00 | $2,160.00 +17.4% · range $1,750.00–$2,450.00 |
Consensus stance | 57% Buy39% Hold4% Sell | 74% Buy26% Hold0% Sell | 73% Buy27% Hold-0% Sell |